Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Ontario-based Andlauer Healthcare Group ships sensitive temperature-controlled products necessary for healthcare manufacturing and research. It has agreed to be acquired by the world’s largest courier, with the all-cash deal expected to close later this year.
The pharmacy chain was accused of filling “millions” of unlawful prescriptions for opioids and other controlled substances. Despite agreeing to the payout, the company does not admit wrongdoing.
Radiology researchers from six leading medical schools have laid out some attuned and readily adoptable strategies for groups challenged to prosper in a time of difficult reimbursement dynamics.
An AI startup has received the FDA’s go-ahead to market a new tool within its existing platform that automatically diagnoses stroke and brain injury in hyperdense brain tissue imaged with unenhanced CT.
A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.
A global tech and pharma vendor is set to inject U.S. healthcare with a set of generic contrast agents, the first of which will be an FDA-approved substitute for GE Healthcare’s Visipaque.
A healthcare AI startup in Silicon Valley is partnering with a top-tier medical school—and hopefully a few good radiologists—to test a hypothesis that’s increasingly crucial to radiology.
GE HealthCare will be the name of the company’s healthcare business, while its energy portfolio will go under the moniker GE Vernova, and its aviation business will be dubbed GE Aerospace.